# DESCRIPTION

## BACKGROUND OF THE INVENTION

- introduce glaucoma
- discuss current surgical treatments
- highlight limitations of current treatments

## SUMMARY OF THE INVENTION

- introduce implant device
- describe microchannel structure
- outline embodiments of device
- summarize method of managing intraocular pressure

## DETAILED DESCRIPTION

- introduce glaucoma surgical devices with microfluidic meshwork

### Definitions

- define technical and scientific terms
- explain usage of articles and terms like "about"

### Glaucoma Drainage Meshwork

- describe mesh implants for glaucoma drainage
- outline structure of mesh 10 with microchannels
- describe properties of microchannels
- explain flexibility and compliance of mesh 10
- describe lattice structure with branches and outlets
- explain drainage rate and characteristics
- show constructions of mesh 10 in 2D and 3D
- describe integration with fluid funneling features
- explain GDI device with interface, distributing section, and mesh 10
- describe MIGS stent device with mesh 10
- explain minimally invasive delivery of MIGS stent device

### Methods of Making

- describe method of making mesh using photolithography
- outline steps of making mesh using photolithography
- describe method of making mesh using drawing and coating
- outline steps of making mesh using drawing and coating
- explain surface treatments for mesh

### Methods of Use

- describe methods of implanting GDI devices
- describe methods of implanting MIGS devices

## EXPERIMENTAL EXAMPLES

- introduce experimental examples

### Example 1: A Novel Flexible Microfluidic Meshwork to Reduce Fibrosis in Glaucoma Surgery

- describe modified GDI concept
- motivate microfluidic meshwork design
- describe meshwork fabrication
- describe animal preparation and standard surgical implantation
- describe histology preparation
- describe statistical considerations
- present results
- describe postoperative visits
- describe histological analysis
- compare fibrotic capsule thickness
- discuss inflammatory cell activation
- justify rabbit model choice
- justify AGV FP7 plate choice
- discuss implications of results

